Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P MICHAEL

Showing results (951-960 of 1,158) with videos related to

Pageof 116
Sort By:
The American Journal of Cardiology|December 29, 2016
Effect of Chronic Kidney Disease on Mortality in Patients Who Underwent Lower Extremity Peripheral Vascular InterventionJoe X Xie, Thomas J Glorioso, Philip B Dattilo, et al.
JAMA|December 10, 2009
Contraindicated medication use in dialysis patients undergoing percutaneous coronary interventionThomas T Tsai, Thomas M Maddox, Matthew T Roe, et al.
BMC Cardiovascular Disorders|September 4, 2017
Adherence and outcomes to direct oral anticoagulants among patients with atrial fibrillation: findings from the veterans health administrationRyan T Borne, Colin O'Donnell, Mintu P Turakhia, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|February 2, 2010
Application of the Margin of Exposure (MOE) approach to substances in food that are genotoxic and carcinogenicDiane Benford, P Michael Bolger, Philip Carthew, et al.
The American Journal of Cardiology|November 16, 2019
Implications of Guideline Updates for the Management of Apparent Treatment Resistant Hypertension in the United States (A NCDR Research to Practice [R2P] Project)Anna M Maw, Lauren E Thompson, P Michael Ho, et al.
Circulation. Cardiovascular Quality and Outcomes|April 1, 2010
Adverse events after stopping clopidogrel in post-acute coronary syndrome patients: Insights from a large integrated healthcare delivery systemP Michael Ho, Thomas T Tsai, Tracy Y Wang, et al.
JACC. Cardiovascular Interventions|June 25, 2011
Safety of contemporary percutaneous peripheral arterial interventions in the elderly insights from the BMC2 PVI (Blue Cross Blue Shield of Michigan Cardiovascular Consortium Peripheral Vascular Intervention) registryBenjamin R Plaisance, Khan Munir, David A Share, et al.
Diabetes, Obesity & Metabolism|September 9, 2020
Potential unrealized mortality benefit of glucagon-like peptide-1 receptor agonists and sodium-glucose co-transport-2 inhibitors: A report from the Veterans Health Administration Clinical Assessment, Reporting and Tracking programTaufiq Salahuddin, Vanessa Richardson, Demetria M McNeal, et al.
Heart (British Cardiac Society)|March 25, 2015
Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarctionSupriya Shore, Philip G Jones, Thomas M Maddox, et al.
Plos One|July 21, 2017
The mitochondrial genome of the terrestrial carnivorous plant Utricularia reniformis (Lentibulariaceae): Structure, comparative analysis and evolutionary landmarksSaura R Silva, Danillo O Alvarenga, Yani Aranguren, et al.
Pageof 116

Showing results (951-960 of 1,158) with videos related to

Sort By:
Pageof 116
The American Journal of Cardiology|December 29, 2016
Effect of Chronic Kidney Disease on Mortality in Patients Who Underwent Lower Extremity Peripheral Vascular InterventionJoe X Xie, Thomas J Glorioso, Philip B Dattilo, et al.
JAMA|December 10, 2009
Contraindicated medication use in dialysis patients undergoing percutaneous coronary interventionThomas T Tsai, Thomas M Maddox, Matthew T Roe, et al.
BMC Cardiovascular Disorders|September 4, 2017
Adherence and outcomes to direct oral anticoagulants among patients with atrial fibrillation: findings from the veterans health administrationRyan T Borne, Colin O'Donnell, Mintu P Turakhia, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|February 2, 2010
Application of the Margin of Exposure (MOE) approach to substances in food that are genotoxic and carcinogenicDiane Benford, P Michael Bolger, Philip Carthew, et al.
The American Journal of Cardiology|November 16, 2019
Implications of Guideline Updates for the Management of Apparent Treatment Resistant Hypertension in the United States (A NCDR Research to Practice [R2P] Project)Anna M Maw, Lauren E Thompson, P Michael Ho, et al.
Circulation. Cardiovascular Quality and Outcomes|April 1, 2010
Adverse events after stopping clopidogrel in post-acute coronary syndrome patients: Insights from a large integrated healthcare delivery systemP Michael Ho, Thomas T Tsai, Tracy Y Wang, et al.
JACC. Cardiovascular Interventions|June 25, 2011
Safety of contemporary percutaneous peripheral arterial interventions in the elderly insights from the BMC2 PVI (Blue Cross Blue Shield of Michigan Cardiovascular Consortium Peripheral Vascular Intervention) registryBenjamin R Plaisance, Khan Munir, David A Share, et al.
Diabetes, Obesity & Metabolism|September 9, 2020
Potential unrealized mortality benefit of glucagon-like peptide-1 receptor agonists and sodium-glucose co-transport-2 inhibitors: A report from the Veterans Health Administration Clinical Assessment, Reporting and Tracking programTaufiq Salahuddin, Vanessa Richardson, Demetria M McNeal, et al.
Heart (British Cardiac Society)|March 25, 2015
Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarctionSupriya Shore, Philip G Jones, Thomas M Maddox, et al.
Plos One|July 21, 2017
The mitochondrial genome of the terrestrial carnivorous plant Utricularia reniformis (Lentibulariaceae): Structure, comparative analysis and evolutionary landmarksSaura R Silva, Danillo O Alvarenga, Yani Aranguren, et al.
Pageof 116